Last checked at | Thursday 27 February | |
| Standard Chartered | Full Year Results (at 0415 GMT) |
| WPP | Full Year Results |
| Flutter Entertainment | Full Year Results |
| Watches of Switzerland | Trading Statement |
| Aston Martin Lagonda | Full Year Results |
| RSA Insurance Group | Full Year Results |
| WPP | Full Year Results |
| Reckitt Benckiser | Full Year Results |
| Persimmon | Full Year Results |
| Mondi | Full Year Results |
| Rentokil Initial | Full Year Results |
| St James's Place | Full Year Results |
| British American Tobacco | Full Year Results |
| Inchcape | Full Year Results |
| Grafton Group | Full Year Results |
| Netcall | Half Year Results |
| PPHE Hotels | Full Year Results |
| Playtech | Full Year Results |
| Macfarlane Group | Full Year Results |
| Haydale Graphene | Half Year Results |
| Hikma Pharmaceuticals | Full Year Results |
| FBD Holdings | Full Year Results |
| Georgia Capital | Full Year Results |
| Drax Group | Full Year Results |
| Provident Financial | Full Year Results |
| Vistry Group | Full Year Results |
| Vesuvius | Full Year Results |
| Ricardo | Full Year Results |
| Evraz | Full Year Results |
| National Express | Full Year Results |
| Amigo Holdings | Full Year Results |
| Genus | Full Year Results |
| Hunting | Full Year Results |
| James Fisher & Sons | Full Year Results |
| Hastings Group Holdings | Full Year Results |
| Howden Joinery Group | Full Year Results |
| Bakkavor | Full Year Results |
| Verona Pharma | Full Year Results |
| Base Resources | Full Year Results |
| Friday 28 February | |
| London Stock Exchange Group | Full Year Results |
| International Consolidated Airlines Group | Full Year Results |
| CRH | Full Year Results |
| Rightmove | Full Year Results |
| Rolls-Royce Holdings | Full Year Results |
| Glenveagh Properties | Full Year Results |
| Surface Transforms | Half Year Results |
| Vitec | Full Year Results |
| Essentra | Full Year Results |
| Tetragon Financial Group | Full Year Results |
| IMI | Full Year Results |
| Man Group | Full Year Results |
| Foxtons | Full Year Results |
| ConvaTec Group | Full Year Results |
| Jupiter Asset Management | Full Year Results |
| Monday 2 March | |
| Johnson Service Group | Full Year Results |
| Greencoat Renewables | Full Year Results |
| Hiscox | Full Year Results |
| Mid Wynd International Investment Trust | Half Year Results |
| Senior | Full Year Results |
| Tuesday 3 March | |
| Intertek | Full Year Results |
| John Laing Group | Full Year Results |
| XP Power | Full Year Results |
| 4imprint Group | Full Year Results |
| Cairn Homes | Full Year Results |
| Fresnillo | Full Year Results |
| Ashtead Group | Q3 Results |
| Hutchison China | Full Year Results |
| Direct Line Insurance | Full Year Results |
| Greggs | Full Year Results |
| Huntsworth | Full Year Results |
| Travis Perkins | Full Year Results |
| GoCo Group | Full Year Results |
| DX Group | Half Year Results |
| Robert Walters | Full Year Results |
| Rotork | Full Year Results |
| Keller | Full Year Results |
| Apax Global Alpha | Full Year Results |
| Craneware | Half Year Results |
| Ibstock | Full Year Results |
| International Game Technology | Q4 Results |
| IWG | Full Year Results |
| Wednesday 4 March | |
| BATM Advanced | Full Year Results |
| Allergy Therpeutucs | Half Year Results |
| Hostelworld Group | Full Year Results |
| Mpac Group | Full Year Results |
| Crystal Amber Fund | Half Year Results |
| Vivo Energy | Full Year Results |
| Legal & General | Full Year Results |
| Polymetal International | Full Year Results |
| TT Electronics | Full Year Results |
| Biffa | Trading Statement |
| Hill & Smith Holdings | Full Year Results |
| Elementis | Full Year Results |
| Copyright 2020 Alliance News Limited. All Rights Reserved. | |
6 Nov 2023 12:33
IN BRIEF: Allergy Therapeutics extends cash runway until end of 2023
Allergy Therapeutics PLC - West Sussex, England-based commercial biotechnology company - Says it continued to work on initiatives to improve cost control and manage working capital alongside trading broadly in line with expectations for the current financial year to date. Says it has extended its cash runway and anticipates to require additional funding by the end of December. Further, says discussions with some major shareholders regarding a subscription and open offer announced in October have progressed. Says that the pivotal phase 3 grass G306 modified allergen tyrosine adsorbed monophosphoryl lipid A trial remains on track to report interim results this month. Via G306, the company aims to release an immunotherapy for grass allergy.
Read more